<DOC>
	<DOCNO>NCT01288079</DOCNO>
	<brief_summary>The purpose study assess safety effect TC-5214 single therapy patient major depressive disorder exhibit inadequate response antidepressant .</brief_summary>
	<brief_title>A Study Assess Safety Effect TC-5214 Patients With Major Depressive Disorder .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Provision sign date informed consent initiation studyrelated procedure . The patient must clinical diagnosis major depressive disorder ( MDD ) inadequate response one antidepressant . Women childbearing potential must negative urine pregnancy test confirm use highly effective form birth control enrollment 3 month last dose study drug . Outpatient status enrollment randomization . Patients lifetime history bipolar disorder ; psychotic disorder posttraumatic stress disorder . Patients history suicide attempt past year and/or see investigator significant history risk suicide homicide . Patients significant unstable hepatic , renal , pulmonary , cardiovascular , ophthalmologic , neurologic , medical condition might confound study put patient great risk study participation . History stroke transient ischemic attack , seizures seizure disorder , head trauma include close head injury . Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Monotherapy</keyword>
	<keyword>Inadequate Response Antidepressant Therapy</keyword>
</DOC>